Eden Research (LON:EDEN) Shares Down 3.3% – Here’s What Happened

Posted by Stacy Sanders on Feb 21st, 2025

Eden Research plc (LON:EDEN – Get Free Report)’s stock price fell 3.3% on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares traded hands during trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26. The stock has a market cap of £18.56 million, a P/E ratio of -12.19 and a beta of 0.92. The business’s 50-day simple moving average is GBX 3.88 and its two-hundred day simple moving average is GBX 3.95.

Insiders Place Their Bets

In other news, insider Alexander John Abrey purchased 540,540 shares of the stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average cost of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,396.86). Also, insider Lykele van der Broek purchased 256,000 shares of the stock in a transaction dated Thursday, February 6th. The stock was purchased at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,975.16). Company insiders own 14.02% of the company’s stock.

Eden Research Company Profile

(Get Free Report)

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.